Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

FOPO nets $6.2mm for NovaBay

Executive Summary

NovaBay Pharmaceuticals Inc. (topical non-antibiotic antimicrobials) netted $6.2mm through the follow-on sale of 5.6mm common shares at $1.20. The company also issued 18-month warrants to buy another 1.4mm shares of common stock exercisable at $1.56 each.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies